These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

56 related items for PubMed ID: 8118804

  • 1. Estradiol inhibits growth of hormone-nonresponsive PC3 human prostate cancer cells.
    Carruba G, Pfeffer U, Fecarotta E, Coviello DA, D'Amato E, Lo Castro M, Vidali G, Castagnetta L.
    Cancer Res; 1994 Mar 01; 54(5):1190-3. PubMed ID: 8118804
    [Abstract] [Full Text] [Related]

  • 2. The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor beta1 (TGFbeta1) signal transduction pathway.
    Jiang J, Sugimoto Y, Liu S, Chang HL, Park KY, Kulp SK, Lin YC.
    Anticancer Res; 2004 Mar 01; 24(1):91-100. PubMed ID: 15015581
    [Abstract] [Full Text] [Related]

  • 3. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
    Jakowlew SB, Moody TW, Mariano JM.
    Anticancer Res; 1997 Mar 01; 17(3C):1849-60. PubMed ID: 9216635
    [Abstract] [Full Text] [Related]

  • 4. Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines.
    Kim IY, Kim BC, Seong DH, Lee DK, Seo JM, Hong YJ, Kim HT, Morton RA, Kim SJ.
    Cancer Res; 2002 Sep 15; 62(18):5365-9. PubMed ID: 12235008
    [Abstract] [Full Text] [Related]

  • 5. Expression of transforming growth factor alpha antisense mRNA inhibits the estrogen-induced production of TGF alpha and estrogen-induced proliferation of estrogen-responsive human breast cancer cells.
    Kenney NJ, Saeki T, Gottardis M, Kim N, Garcia-Morales P, Martin MB, Normanno N, Ciardiello F, Day A, Cutler ML.
    J Cell Physiol; 1993 Sep 15; 156(3):497-514. PubMed ID: 8360257
    [Abstract] [Full Text] [Related]

  • 6. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
    Zheng J, Kulp SK, Zhang Y, Sugimoto Y, Dayton MA, Govindan MV, Brueggemeier RW, Lin YC.
    Anticancer Res; 2000 Sep 15; 20(1A):11-9. PubMed ID: 10769629
    [Abstract] [Full Text] [Related]

  • 7. Functional estrogen receptor beta in colon cancer cells.
    Fiorelli G, Picariello L, Martineti V, Tonelli F, Brandi ML.
    Biochem Biophys Res Commun; 1999 Aug 02; 261(2):521-7. PubMed ID: 10425218
    [Abstract] [Full Text] [Related]

  • 8. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells.
    Seth D, Shaw K, Jazayeri J, Leedman PJ.
    Br J Cancer; 1999 May 02; 80(5-6):657-69. PubMed ID: 10360641
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y, Kyprianou N.
    Cell Growth Differ; 1998 Feb 02; 9(2):185-93. PubMed ID: 9486855
    [Abstract] [Full Text] [Related]

  • 10. Estrogen induction of smooth muscle differentiation of human prostatic stromal cells is mediated by transforming growth factor-beta.
    Hong JH, Song C, Shin Y, Kim H, Cho SP, Kim WJ, Ahn H.
    J Urol; 2004 May 02; 171(5):1965-9. PubMed ID: 15076322
    [Abstract] [Full Text] [Related]

  • 11. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N.
    Prostate; 2008 Feb 15; 68(3):287-95. PubMed ID: 18163430
    [Abstract] [Full Text] [Related]

  • 12. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells.
    Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Sensibar JA, Kim JH, Kato M, Lee C.
    Cancer Res; 1996 Jan 01; 56(1):44-8. PubMed ID: 8548772
    [Abstract] [Full Text] [Related]

  • 13. The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP.
    Kim IY, Zelner DJ, Lee C.
    Exp Cell Res; 1998 May 25; 241(1):151-60. PubMed ID: 9633523
    [Abstract] [Full Text] [Related]

  • 14. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
    Gucev ZS, Oh Y, Kelley KM, Rosenfeld RG.
    Cancer Res; 1996 Apr 01; 56(7):1545-50. PubMed ID: 8603400
    [Abstract] [Full Text] [Related]

  • 15. Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells.
    Evangelou A, Jindal SK, Brown TJ, Letarte M.
    Cancer Res; 2000 Feb 15; 60(4):929-35. PubMed ID: 10706107
    [Abstract] [Full Text] [Related]

  • 16. Expression of Nkx3.1 enhances 17beta-estradiol anti-tumor action in PC3 human prostate cancer cells.
    Wang P, Liu B, Luo JD, Zhang ZG, Ma Q, Chen ZD.
    Asian J Androl; 2007 May 15; 9(3):353-60. PubMed ID: 17486276
    [Abstract] [Full Text] [Related]

  • 17. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S, Krishnan AV, Feldman D.
    Clin Cancer Res; 2000 Aug 15; 6(8):3371-9. PubMed ID: 10955825
    [Abstract] [Full Text] [Related]

  • 18. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma.
    Ripley D, Tang XM, Ma C, Chegini N.
    Gynecol Oncol; 2001 May 15; 81(2):301-9. PubMed ID: 11330966
    [Abstract] [Full Text] [Related]

  • 19. Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.
    Letsch M, Schally AV, Szepeshazi K, Halmos G, Nagy A.
    Clin Cancer Res; 2003 Oct 01; 9(12):4505-13. PubMed ID: 14555524
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2.
    Joyce NC, Harris DL, Mello DM.
    Invest Ophthalmol Vis Sci; 2002 Jul 01; 43(7):2152-9. PubMed ID: 12091410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.